Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This phase II trial evaluated the impact of giving docetaxel together with lycopene
supplements in treating patients with hormone-resistant prostate cancer not previously
treated with chemotherapy. Drugs used in chemotherapy, such as docetaxel, work in different
ways to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Chemoprevention is the use of certain drugs, such as lycopene, to keep cancer from
forming. Giving docetaxel together with lycopene may be an effective treatment for prostate
cancer.